SCHEMBL1630370

SCHEMBL1630370

COc1cc(OC)c(S(=O)(=O)N(C)CC(O)CO)cc1-c1ccnn1-c1ccccc1Cl

nearest known ligand 0.38

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 4/20 0.38
SLC16A3 O15427 4/20 0.35
SLC16A1 P53985 3/20 0.35
NR3C2 P08235 2/20 0.34
KCNN4 O15554 1/20 0.33
RAB9A P51151 1/20 0.32
PDE11A Q9HCR9 1/20 0.32
MAPK14 Q16539 1/20 0.32
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
GLA P06280 1/20 0.31
TSHR P16473 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1629173 0.88 HSP90AA1 (0.38) HSP90AA1SLC16A3SLC16A1NR3C2KCNN4
SCHEMBL1630004 0.87 HSP90AA1 (0.38) HSP90AA1SLC16A3SLC16A1NR3C2KCNN4
SCHEMBL1629889 0.86 HSP90AA1 (0.43) HSP90AA1SLC16A3SLC16A1NR3C2KCNN4
SCHEMBL1631603 0.85 HSP90AA1 (0.37) HSP90AA1SLC16A3SLC16A1NR3C2KCNN4
SCHEMBL1216917 0.85 MAPT (0.44) HSP90AA1SLC16A3SLC16A1MEN1KMT2A
SCHEMBL1631566 0.85 TSHR (0.44) HSP90AA1SLC16A3SLC16A1NR3C2KCNN4
SCHEMBL1628570 0.84 HSP90AA1 (0.39) HSP90AA1SLC16A3SLC16A1NR3C2RAB9A
SCHEMBL1630393 0.83 HSP90AA1 (0.38) HSP90AA1SLC16A3SLC16A1NR3C2KCNN4
SCHEMBL1630395 0.82 HSP90AA1 (0.35) HSP90AA1SLC16A3SLC16A1NR3C2KCNN4
SCHEMBL1630236 0.82 ALDH1A1 (0.41) HSP90AA1SLC16A3SLC16A1PDE11AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885SLC16A3 4504/4885SLC16A1 4124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.